Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group

American Journal of Infection Control

Volumn 36, Issue 4 SUPPL., 2008, Pages

  Song, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TEICOPLANIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; ASIA; CHINA; CONSENSUS DEVELOPMENT; DRUG COST; DRUG FORMULATION; DRUG SPECIFICITY; HEALTH SURVEY; HONG KONG; HOSPITAL INFECTION; HUMAN; INFECTION RESISTANCE; MORBIDITY; MORTALITY; PHILIPPINES; PNEUMONIA; PRACTICE GUIDELINE; TAIWAN; TREATMENT PLANNING; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; ASIA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 43149084577     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2007.01.015     Document Type: Article

References (31)

1. American Thoracic Society, Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med 171 (2005) 388-416
2. British Thoracic Society Standards of Care Committee. BTS Guidelines for the management of community-acquired pneumonia in adults. Thorax 56 suppl 4 (2001) IV1-IV64
3. rd ed). Hong Kong: 2005. p. 68. Adapted from Brown EM. Empirical antimicrobial therapy of mechanically ventilated patients with nosocomial pneumonia. J Antimicrob Chemother 40 (1997) 463-468
4. Chinese Medical Association, Respiratory Branch. Treatment guidelines for hospital-acquired pneumonia. Chin J Tuber Respir Dis 22 (1999) 201-202
5. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventative strategies. Am J Respir Crit Care Med 153 (1995) 1711-1725
6. Fowler R.A., Flavin K.E., Barr J., Weinacker A.B., Parsonnet J., and Gould M.K. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest 123 (2003) 835-844
7. Mohanty S., Singhal R., Sood S., Dhawan B., Das B.K., and Kapil A. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against Gram-negative bacteria. Indian J Med Res 122 (2005) 425-428
8. Rubinstein E., Cammarata S., Oliphant T., Wunderlink R., and Linezolid Nosocomoal Pneumonia Study Group. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 32 (2001) 402-412
9. Wunderink R.G., Cammarata S.K., Oliphant T., Kollef M.H., and Linezolid Nosocomoal Pneumonia Study Group. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 25 (2003) 980-982
10. Van Eldere J. Multicenter surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 51 (2003) 347-352
11. Landman D., Quale J.M., Mayorga D., Adedeji A., Vangala K., Ravishankar J., et al. Citywide clonal outbreak due to a multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 162 (2002) 1515-1520
12. Dubois V., Arpin C., Melon M., Melon B., Andre C., Frigo C., et al. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance. J Clin Microbiol 39 (2001) 2072-2078
13. Scheld W.M. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 9 (2003) 1-9
14. Neuhauser M.M., Weinstein R., Rydman R., Danziger L.H., Karam G., and Quinn J.P. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289 (2003) 885-888
15. Linden P.K., Kusne S., Coley K., Fontes P., Kramer D.J., and Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37 (2003) e154-e160
16. Hamer D.H. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistnat Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 162 (2000) 328-330
17. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of MDR Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiologic features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 (2001) S104-S113
18. Nordmann P., and Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 8 (2002) 321-331
19. Wood G.C., Hanes S.D., Croce M.A., Fabian T.C., and Boucher B.A. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infect Dis 34 (2002) 1425-1430
20. Kwa A.L., Loh C., Low J.G., Kurup A., and Tam V.H. Nebulized colistin in the treatmentof pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 41 (2005) 754-757
21. Falagas M.E., Kasiakou S.K., Tsiodras S., and Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 4 (2006) 138-146
22. Luzzaro F., Mezzatesta M., Mugnaioli C., Perilli M., Stefani S., Amicosante G., et al. Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44 (2006) 1659-1664
23. Jones R.N., Rhomberg P.R., Varnam D.J., and Mathai D. A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multidrug resistant Gram-negative bacilli including bacteraemic Salmonella spp: initial studies for the MYSTIC Programme in India. Int J Antimicrob Agents 20 (2002) 426-431
24. Yu Y., Zhou W., Chen Y., Ding Y., and Ma Y. Epidemiological and antibiotic-resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province. Chin Med J (Engl) 115 (2002) 1479-1482
25. Chastre J., Wolff M., Fagon J.Y., Chevret S., Thomas F., Wermert D., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290 (2003) 2588-2598
26. Gerding D.N., Larson T.A., Hughes R.A., Weiler M., Shanholtzer C., and Peterson L.R. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35 (1991) 1284-1290
27. Kollef M.H., Vlasnik J., Sharpless L., Pasque C., Murphy D., and Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 156 (1997) 1040-1048
28. Gruson D., Hilbert G., Vargas F., Valentino R., Bebear C., Allery A., et al. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Am J Respir Crit Care Med 162 (2000) 837-843
29. Gruson D., Hilbert G., Vargas F., Valentino R., Bui N., Pereyre S., et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 31 (2003) 1908-1914
30. Rahal J.J., Urban C., Horn D., Freeman K., Segal-Maurer S., Maurer J., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280 (1998) 1233-1237
31. Hsueh P.R., Chen W.H., and Luh K.T. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26 (2005) 463-472